{"name":"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","slug":"instituto-de-investigaci-n-sanitaria-de-la-fundaci-n-jim-nez-d-az","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Antiasthmatic","genericName":"Antiasthmatic","slug":"antiasthmatic","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Antiasthmatic","genericName":"Antiasthmatic","slug":"antiasthmatic","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxPRy04azZTZTV3OFpybnI2R1RPMVZaVEx2TGZnNFM3UWhsLS1hZ0NHNy1FZm1DOUhQcXFYQzVYNy1FdldCWnVqbTBIQUdHeW95N3pIUEo0bk5tSWlualM1WUNKZWQ3c0R3b0llQ0VaamRERTJ0SkxadjRNVllPNWxnM3FseGQ5Szc4YktfUGp3MG8zMk9Cbmx0cmtlcWxzanFoNFVIaXZnYVhSMy1MZ080Q0Ewb3UyZWdMNTVMTUkzbDNDd0xHSUEyeThvZC1WVzJqQmNCZkdFWk51SjFBN29vVVRsTE9vcDJET01xVXBjWGRNN3ROM3dhd25lZlJpSDgtSC1mYWZkT3RVamdLdUN2SW5RQ3hLU2QzNDU2THgwWEcyaktqYk53aTF3?oc=5","date":"2025-10-14","type":"regulatory","source":"businesswire.com","summary":"Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I) - businesswire.com","headline":"Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment of Severe Leukocyte A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1QRFdqWmhicFozVGNWTjA3Z29XSnJzU3lCR0h3Mk5WTzc1RkRrMzRNUFF5V1h4ekZCamdTMFRiRjJQQ3NuejI5a3FtdzJ1UmIzdWxremZ4enM2WXE2bk1J?oc=5","date":"2025-07-02","type":"pipeline","source":"NEJM","summary":"Intensive Blood-Pressure Control in Patients with Type 2 Diabetes - NEJM","headline":"Intensive Blood-Pressure Control in Patients with Type 2 Diabetes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE05NlhBYVA5OUxKX0NnMTNfZXo4NTRzTTNESWxVa2FUSGdzbjgwamhlN2NXQnFpUFZEMVZsUUQ2VzZkaGdLUGg0VU5NOHRmcE5iQ3loaXlBMzhZVjRmVGh6TU5kb3JoRklY?oc=5","date":"2024-12-16","type":"pipeline","source":"Wiley Online Library","summary":"Alimentary Pharmacology & Therapeutics | Pharmacology Journal - Wiley Online Library","headline":"Alimentary Pharmacology & Therapeutics | Pharmacology Journal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFBRQjdFUG1oc2VkdzNFY3JBUkxOamRCaERxNUZzMnRBTmQxc1Q0REpPZTFRRmdFbVJKM054d2hnRmZaVm1wZ09KSE5EOXlTbTNWTm5iYjJkTktmMHlw?oc=5","date":"2022-08-02","type":"pipeline","source":"Medscape","summary":"El pico estacional de leucemia mieloide aguda suscita una causa viral o medioambiental - Medscape","headline":"El pico estacional de leucemia mieloide aguda suscita una causa viral o medioambiental","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}